Argitalpenak (36) Ikertzaileren baten partaidetza izan duten argitalpenak

2024

  1. Bioanalytical strategies to evaluate cisplatin nanodelivery systems: From synthesis to incorporation in individual cells and biological response

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 237

  2. Biomarkers in Ovarian Cancer: Towards Personalized Medicine

    Proteomes, Vol. 12, Núm. 1

  3. Characterization of Human B Cell Hematological Malignancies Using Protein-Based Approaches

    International Journal of Molecular Sciences, Vol. 25, Núm. 9

  4. Coronary Ectasia and Antinuclear Antibodies: Another Clue to the Role of Immunology in Vascular Disease

    American Journal of Cardiology

  5. Immunology and atherosclerosis: is there an individual ID which defines our susceptibility?

    European heart journal

  6. Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells

    Science Immunology, Vol. 9, Núm. 91

  7. Targeting Inflammation and Immunology: A Hope for the Frequent Flyers?

    JACC: Cardiovascular Interventions

  8. The management of cardiovascular risk in psoriatic disease: A bridge over troubled water

    Seminars in Arthritis and Rheumatism, Vol. 65

  9. Type I interferon pathway activation across the antiphospholipid syndrome spectrum: associations with disease subsets and systemic antiphospholipid syndrome presentation

    Frontiers in Immunology, Vol. 15

2023

  1. 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 1, pp. 48-56

  2. 2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 6, pp. 754-762

  3. Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider

    RMD Open, Vol. 9, Núm. 1

  4. Association of gamma glutamyl transferase in the presence and progression of abdominal aortic calcifications and changes to bone mineral density

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 15, Núm. 3, pp. 93-99

  5. Association of vocational interventions and work-related factors with disease and work outcomes in people with RMDs: A systematic review

    Seminars in Arthritis and Rheumatism, Vol. 58

  6. Cardiovascular Risk Factors and Events in Fibromyalgia Patients

    The Israel Medical Association journal : IMAJ, Vol. 25, Núm. 9, pp. 627-630

  7. Comment: Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis and pathogenic pathways during early arthritis stages: Reply

    Rheumatology (Oxford, England), Vol. 62, Núm. 10, pp. e301-e302

  8. Developing a framework for the implementation of recommendations for lifestyle factors for people with RMDs across Europe: assessment of current materials and implementation needs

    RMD open, Vol. 9, Núm. 3

  9. Diagnosis and management of cardiovascular risk in rheumatoid arthritis: main challenges and research agenda

    Expert Review of Clinical Immunology, Vol. 19, Núm. 3, pp. 279-292

  10. Diagnostic Performance of Anti-dsDNA Tests by Indirect Immunofluorescence and Enzyme-linked Immunosorbent Assay in Patients with Systemic Lupus Erythematosus

    Journal of Applied Laboratory Medicine, Vol. 8, Núm. 4, pp. 713-725

  11. Editorial: Global excellence in rheumatology: Europe

    Frontiers in Medicine